Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells - Université Toulouse - Jean Jaurès Access content directly
Journal Articles Cancer Letters Year : 2015

Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells

Inna Zubrilov
  • Function : Author
Orit Sagi-Assif
  • Function : Author
Sivan Izraely
  • Function : Author
Tsipi Meshel
  • Function : Author
Shlomit Ben-Menahem
  • Function : Author
Ravit Ginat
  • Function : Author
Metsada Pasmanik-Chor
  • Function : Author
G.S.W. Faculty of Life Sciences [Tel Aviv]
Clara Nahmias
Institut Cochin
Pierre-Olivier Couraud
  • Function : Author
Institut Cochin
Dave S.B. Hoon
  • Function : Author
Isaac Witz
  • Function : Author

Domains

Life Sciences [q-bio] Cancer Cellular Biology

Clara NAHMIAS  : Connect in order to contact the contributor

https://hal-univ-tlse2.archives-ouvertes.fr/hal-02411572

Submitted on : Sunday, December 15, 2019-1:14:49 AM

Last modification on : Friday, March 24, 2023-2:53:14 PM

Not file

Dates and versions

hal-02411572 , version 1 (15-12-2019)

Identifiers

Cite

Inna Zubrilov, Orit Sagi-Assif, Sivan Izraely, Tsipi Meshel, Shlomit Ben-Menahem, et al.. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells. Cancer Letters, 2015, 361 (1), pp.86-96. ⟨10.1016/j.canlet.2015.02.041⟩. ⟨hal-02411572⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-TLSE2 CNRS UP-SANTE
25 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More